FGF2 binds to FGFR1, which is a tyrosine kinase receptor mostly expressed on EC, and the downstream signaling favors angiogenesis in two ways: a) modulation of EC activity and (b) regulation of VEGF expression by the tumor cells [99]. The gene discussed is NTRK1; the disease is neoplasm.